NanoBio First - Funding Program for World-Leading Innovative R&D on Science and Technology_[Development of Innovative Diagnostic and Therapeutic Systems Based on Nanobiotechnology]

NanoBio-First Website

Outline

Home>
Member / Advisory Board

Advisory Board

Hideo UTSUMI	Pharmaceuticals and Medical Devices Agency, Japan, Executive Director
Tadao KAKIZOE	Japan Cancer Society, President
Fumihiko KAJIYA	Kawasaki University of Medical Welfare, Professor
Touichi TAKENAKA	Japan Health Sciences Foundation Chairman

NanoBio First - Funding Program for World-Leading Innovative R&D on Science and Technology
- Development of Innovative Diagnostic and Therapeutic Systems Based on Nanobiotechnology